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Dietary and Hormonal Factors in Relation to Physical Function 
ABSTRACT 
 
Physical function is increasingly recognized as a key component of healthy aging, in 
particular as a core component of mobility and independent living in older adults. Prior research 
has also demonstrated that poor physical function is related to hospitalization, long-term nursing 
home care, and increased mortality among older adults. Women appear to have a greater burden 
of physical function impairment, although it is not certain whether this is due to gender 
differences in reporting of impairments, risk factor differences, or biologic differences. 
 
In this dissertation, I examined not only risk factors for development of physical function 
impairment, but also explanations for apparent gender differences. First, while diet is related to 
numerous chronic diseases and conditions of aging, limited research has examined the role of 
diet, which may be an important strategy to prevent or delay decline in physical function with 
aging. In Chapter 1, I prospectively examined the association between the Alternative Healthy 
Eating Index-2010 (AHEI-2010), a measure of diet quality, with incident impairment in physical 
function among 54,762 women from the Nurses’ Health Study. Overall, participants in higher 
quintiles of the AHEI-2010, indicating a healthier diet, were less likely to have incident physical 
impairment versus participants in lower quintiles over the 18 year follow-up period.
iii 
There are established sex differences in later life physical function, with a greater number 
of impairments in function and steeper rates of decline observed among women compared to 
men. It is hypothesized that some of the differences could be due to women’s greater likelihood 
to report symptoms compared to men. Few prospective studies have investigated possible risk 
factor differences or differences in biological factors between men and women. In Chapter 2, I 
present the findings from an analysis investigating sex differences in relation to physical function 
decline. Overall, women had lower physical function scores at baseline and steeper rates of 
decline compared to men.  These differences were partially explained by the difference in risk 
factors between men and women, indicating that it could be of particular importance to intervene 
on risk factors in women to prevent further physical function impairments with aging. 
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1 
INTRODUCTION 
 
The proportion of the population 65 years and older in the United States is expected to increase 
to nearly 20% by the year 2030 (1). Physical function is increasingly recognized as a key 
component of healthy aging, in particular as a core component of mobility and independent 
living in older adults. Prior research has also demonstrated that poor physical function is related 
to hospitalization (2), long-term nursing home care (3,4), and increased mortality among older 
adults (4,5). Women appear to have a greater burden of physical function impairment (6), 
although it is not certain whether this is due to gender differences in reporting of impairments or 
to risk factor or biologic differences- thus it is unclear whether women may merit increased 
focus for preventive interventions. 
 
In this dissertation, I examined not only risk factors for development of physical function 
impairment, but also explanations for apparent gender differences. First, while diet is related to 
numerous chronic disease and conditions of aging, surprisingly little research has examined diet 
and onset of physical function impairments. Studying dietary patterns is important to capture the 
whole diet and interactions between different dietary components; moreover diet patterns are 
more readily incorporated into easily understood advice for individuals (7). The Healthy Eating 
Index was created to evaluate diet quality, based on USDA diet guidelines. The Alternative 
Healthy Eating Index-2010 (AHEI-2010) was created to better focus on specific foods and 
nutrients predictive of chronic disease risk (8). The AHEI-2010 emphasizes the intake of whole 
versus refined grains and distinguishes proteins based on individual health impacts (e.g. nuts, 
legumes, and red and processed meats are considered separately) (8). The AHEI-2010 has been 
2 
associated with a better lipid profile, lower levels of inflammatory markers, and a lower risk of 
clinical vascular disease- all of which contribute to physical function (9-11). 
 
The meager prior literature supports an association between diet quality and physical function; 
however, the majority of studies have been cross-sectional with modest sample sizes (12-15). In 
cross-sectional studies, it is plausible that better physical function may lead to better diet rather 
than the reverse. To our knowledge, there has been only one prospective study conducted. 
Among 3,000 participants in a French cohort of middle-aged adults, those with the best 
adherence to a pre-specified dietary guideline had an increased physical function score, as 
measured by the SF-36, over the 12 year follow-up period (16). 
 
Finally, there are established sex differences in later life physical function, with a greater number 
of impairments in function and steeper rates of decline observed among women compared to 
men (6,17-19). It is hypothesized that some of the differences could be due to women’s greater 
likelihood to report symptoms compared to men (20). There have been few prospective studies 
that have investigated possible risk factors differences or differences in biological factors 
between men and women. Thus, evaluation of risk factors profiles and plasma hormone levels in 
relation to physical function is a clear initial step in identifying the mechanism underlying these 
apparent gender disparities. 
3 
Overall, this research will provide results which will significantly enhance the current literature 
and permit better evaluation of diets which may be related to better physical function. This work 
will also allow a deeper understanding of sex differences in physical function decline and 
provide evidence as to whether gender differences may be due to risk factors or biological 
factors, as opposed to reporting differences in men and women. 
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ABSTRACT 
 
Background: Physical function is integral to healthy aging, in particular as a core component of 
mobility and independent living in older adults, and is a strong predictor of mortality. Limited 
research has examined the role of diet, which may be an important strategy to prevent or delay 
decline in physical function with aging. 
Methods: We prospectively examined the association between the Alternative Healthy Eating 
Index-2010 (AHEI-2010), a measure of diet quality, with incident impairment in physical 
function, measured by the Medical Outcomes Short Form-36 (SF-36) physical function scale, 
administered every 4 years from 1992-2008, among 54,762 women from the Nurses’ Health 
Study. Cumulative average diet was assessed using food frequency questionnaires, administered 
approximately every 4 years. We used multivariable cox proportional hazards models to estimate 
the hazard ratios of incident impairment of physical function. 
Results: Participants in higher quintiles of the AHEI-2010, indicating a healthier diet, were less 
likely to have incident physical impairment versus participants in lower quintiles (P-
trend<0.001). The multivariable-adjusted hazard ratio of physical impairment for those in the top 
versus bottom quintile of AHEI-2010 was 0.87 (95% CI: 0.84, 0.90).  For individual AHEI-2010 
components, higher intake of vegetables (P-trend=0.003) and fruits (P-trend=0.02), and lower 
intake of sugar-sweetened beverages (P-trend<0.001), trans fat (P-trend=0.03), sodium (P-
trend<0.001), and moderate alcohol (P-trend <0.001) were each significantly associated with 
reduced rates of incident physical impairment. Among top contributors to the food components 
of the AHEI-2010, the strongest relations were found for increased intake of oranges, orange 
juice, apple/pears, romaine lettuce, and walnuts. However, associations with each component and 
9 
 
with specific foods were generally weaker than the overall score, indicating that overall diet 
pattern appears more important than individual parts. 
Conclusions: In this large cohort of older women, a healthier diet was associated with a lower 
risk of developing impairments in physical function. 
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INTRODUCTION 
   
In the U.S., the proportion of the population 65 years or older is expected to reach nearly 20% by 
the year 2030 (1). Physical function is increasingly recognized as key to healthy aging, in 
particular as a core component of mobility and independent living in older adults. Prior research 
has demonstrated that poor physical function is related to hospitalization (2), long-term nursing 
home care (3,4), and increased mortality (4,5) among older adults. It is thus critical to identify 
modifiable factors which might prevent or delay physical function decline. 
 
The Alternative Healthy Eating Index 2010 (AHEI-2010) was created as an update to the 
Alternative Healthy Eating Index and incorporates foods and nutrients predictive of chronic 
disease risk (6). The AHEI-2010 emphasizes the intake of whole versus refined grains and 
distinguishes proteins based on individual health impacts (e.g., nuts, legumes, fish, and red and 
processed meats are considered separately) (6). Higher adherence to the AHEI-2010 has been 
associated with better lipid and inflammatory profile, and decreased risk of clinical vascular 
disease (6). These factors have all been previously related to physical function (7-9). Prior 
studies have also indicated that low intake of some micronutrients may be associated with 
reduced physical performance, indicating that diet may play an important role in the prevention 
of impairment in physical function (10). 
 
However, to our knowledge, there has been one long-term prospective study on the relationship 
between diet quality and physical function. Thus, we utilized data from 54,762 participants from 
the Nurses’ Health Study to examine the association between the Alternative Healthy Eating 
Index-2010 and incident impairment in physical function over 18 years of follow-up.  
11 
 
METHODS 
 
Study Population 
 
The Nurses’ Health Study (NHS) began in 1976, when female registered nurses, aged 30-55 
years, completed a mailed questionnaire on their health and lifestyle.  Follow-up questionnaires 
have been mailed to participants every two years thereafter and follow-up remains complete for 
>90%. Beginning in 1980, a food-frequency questionnaire (FFQ) was included, which was 
repeated in 1984, 1986 and every 4 years thereafter (11). In 1992, 1996, 2000, 2004 and 2008, 
the Medical Outcomes Study Short- From-36 (SF-36) was administered, a 36 item-questionnaire 
which evaluates eight health concepts, including physical functioning.  The study was approved 
by the Institutional Review Board of Brigham and Women’s Hospital (Boston, MA). 
 
Diet Assessment 
On the FFQ, participants report the average frequency of food consumption during the previous 
year, by specified units or standard portion sizes, using nine possible responses ranging from 
‘never or less than once per month’ to ‘six or more times per day’. The FFQ in the NHS has been 
validated carefully against repeated 7-day diet records and reproducibility of the dietary 
questionnaires has been documented (12, 13).  
 
Criteria and methods for scoring of the AHEI-2010 have been previously described in detail (6); 
the AHEI-2010 was developed to incorporate data from food frequency questionnaires (6). 
Briefly, the AHEI-2010 consists of 11 components: 6 components for which higher intakes are 
better (vegetables, fruit, whole grains, nuts and legumes, long-chain omega-3 fatty acids, 
polyunsaturated fatty acids [PUFAs]); 1 component for which moderate intake is better (alcohol: 
12 
 
2.5 or more drinks per day is assigned 0 points, non-drinkers are assigned 2.5 points, and 0.5-1.5 
drinks per day is assigned 10 points); and 4 components for which lower intake is better (sugar-
sweetened beverages and fruit juice, red and processed meat, trans fat, and sodium). Each 
component is given a minimal score of 0 to indicate “worst” level of intake and a maximum 
score of 10 to indicate “best” level of intake, with intermediate values scored proportionally. 
“Best” levels of intake were determined a priori and based on a combination of the current 
dietary guidelines and the scientific literature regarding the dietary factor and chronic disease 
risk.  All of the component scores are summed to obtain the total AHEI-2010 score, with a range 
from 0 (non-adherence) to 110 (perfect adherence). For these analyses, to reduce measurement 
error and to represent long-term dietary intake, the cumulative average of all AHEI-2010 scores 
from 1980 to the start of a given follow-up period was calculated at each 4-year follow-up cycle. 
Thus, since baseline physical function in this analysis was 1992, at the first follow-up cycle we 
averaged all dietary assessments from 1980 through 1990 (see Figure 1.1); at each subsequent 
follow-up cycle, another year of diet data were incorporated into the cumulative average.    
 
 
Figure 1.1. Timeline for data collection in the Nurses’ Health Study. 
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Physical Function 
 
Information on physical function was collected using the Medical Outcomes Short Form (SF)-36 
questionnaire, a widely used and validated instrument (14). The physical function score (PFS) is 
a consistent and reliable predictor of morbidity and mortality in a variety of populations 
(5,15,16). The PFS was administered to participants starting in 1992 and every four years 
thereafter, and is comprised of 10 questions regarding physical limitations in performing the 
following activities: bathing/dressing yourself, walking one block, walking several blocks, 
walking more than one mile, bending/kneeling, climbing stairs, lifting groceries, moderate 
activities and vigorous activities. Each question has the same three response choices; each 
answer of ‘Yes, limited a lot’ is assigned one point, an answer of ‘Yes, limited a little’ is 
assigned two points, and an answer of ‘No, not limited at all’ is assigned three points. A raw 
score is calculated from the set of 10 questions and ranges from a minimum of 10 points to a 
maximum of 30 points.  The raw score is then transformed to a 100-point scale. A PFS score of 
100 is considered highest physical function and a score of 80 or less is considered significant 
physical impairment (17); this cutpoint has been used in other epidemiologic studies (17, 18). At 
the end of each follow-up cycle, incident cases of impairment were defined as a PFS decreasing 
to 80 or below. As an additional way to test the face validity of the PFS scoring in our cohort, we 
found that only 10% of participants who scored above 80 on the PFS reported adverse physical 
impact on their ability to perform their work or other daily activities; in contrast, 40% of even 
those who scored between 70 and 80 also reported limitations in daily activities due to physical 
health. Thus, multiple lines of evidence support this cutpoint. 
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Statistical Analysis 
 
Women were excluded from this analysis if they did not complete the FFQ at analytic baseline, 
or had an unreasonably high (>3,500 kcal/ day) or low (<500 kcal/day) caloric intake. 
Additionally, women with prevalent physical impairment (physical function score [PFS] ≤80) in 
1992, or women who were missing information on either the AHEI-2010 or PFS score at 
baseline were excluded from this analysis. The final baseline population included 54,762 women 
in 1992.  
 
To evaluate the association between quintiles of the AHEI-2010 score and incident impairment 
in physical function, we used age adjusted and multivariable adjusted Cox proportional hazards 
models. Socio-demographic, lifestyle, and health-related covariates were obtained from the 
questionnaires and updated at each four-year time period in the analysis.  Multivariable adjusted 
models included primary, a priori risk factors for physical function impairment: BMI 
(continuous), total caloric intake (quintiles), physical activity (<3.0, 3.0-8.9, 9.0-17.9, 18.0-26.9, 
≥27 METs/ week), SF-36 Mental Health Index score (continuous), smoking status (never, past, 
current 1-14 cigarettes per day, current 15-24 cigarettes per day, ≥25 cigarettes per day), history 
of hypertension (yes/no), high cholesterol (yes/no), myocardial infarction (yes/no), stroke 
(yes/no), and type 2 diabetes (yes/no). There were few missing data, but missing data on BMI, 
physical activity, and smoking status were accounted for by carrying forward data from the 
previous questionnaire cycle or creating a missing indicator variable.   In the Cox proportional 
hazards models examining the individual components of the AHEI-2010 score, we adjusted for 
the same potential confounders and also included, simultaneously in the model, the AHEI-2010 
score without the component of interest. Since physical activity is so highly related to physical 
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function, we modeled physical activity as a continuous variable, categorical variable, and also 
conducted models with and without physical activity, and with and without updating physical 
activity at each time point.  
 
We also conducted analyses in which we investigated the relationship between the top 5 
contributors to the food component groups based on caloric intake in the study population: fruit, 
vegetable, nuts/legumes, red/processed meats or sugar-sweetened beverages. The specific foods 
were categorized into servings of ‘never or <1 per month’, ‘1-3 times per month’, ‘1 per week’, 
or ‘≥2 per week’. These are the response categories provided on the FFQ, with the top categories 
of intake collapsed into one category due to smaller numbers. For the nuts/legumes component 
(but not for primary analyses of nuts), we began follow-up in 1998 since more detailed 
information on specific type of nuts eaten was collected on the 1998 FFQ permitting specific 
analyses of different nut types. Tests for trend across quintiles of the total AHEI-2010 score and 
score components were calculated by treating the categories as an ordinal variable in the 
proportional hazards models and assigning the median value for that category.  
 
To assess possible sources of bias, especially due to the possibility that women with early signs 
of physical function decline may change their diet, we conducted several secondary analyses. 
First, we conducted analyses in which we excluded participants with a borderline PFS (>80 to 85 
points) at the start of each follow-up period. In another analysis, we imposed a 6 year lag period 
between diet assessment and physical function assessment. In additional research to consider diet 
at mid-life, we also investigated the association between diet score at baseline and subsequent 
physical function. Since vascular factors could be potential intermediates, we also constructed 
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multivariable models without these factors.  To further consider vascular factors, we constructed 
models among those with and without hypertension at baseline and among those with and 
without high cholesterol at baseline. Lastly, we conducted analyses to examine effect 
modification by age by separately examining women less than 59, 60 to 66, and greater than 66 
years at analytic baseline in 1992. All analyses were conducted in SAS version 9.3 (SAS 
Institute, Cary, NC, USA). 
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RESULTS 
Characteristics of the Study Population 
 
Characteristics of women according to quintiles of the AHEI-2010 at baseline in 1992 are 
presented in Table 1.1. In these descriptive results, there were few apparent differences in health 
and lifestyle characteristics of women across AHEI-2010 categories. However, 8.6% of women 
in the highest quintile (i.e. healthiest diet) of AHEI-2010 were current smokers, 16.1% had 
master’s or doctoral degrees, and mean METs/week were 27.8; in the lowest AHEI quintile, 
19.8% of women were current smokers, 6.4% had master’s or doctoral degrees, and mean 
METs/week were 15.9. 
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Table 1.1. Age-standardized baseline characteristics in 1992, according to quintiles of the 
Alternative Healthy Eating Index-2010 
 AHEI-2010 
 Quintile 1 
Median=38 
Quintile 2 
45 
Quintile 3 
50 
Quintile 4 
56 
Quintile 5 
64 
 (n=9,748) (n=10,707) (n=10,874) (n=11,535) (n=11,898) 
Mean age
1
, yr 53.9 (6.9) 55.0 (7.0) 55.8 (7.0) 56.6 (6.9) 57.8 (6.8) 
BMI, kg/m
2
 25.3 (4.7) 25.4 (4.6) 25.3 (4.6) 25.2 (4.6) 24.7 (4.3) 
Physical Activity 
(METs/week) 
15.9 (19.2) 18.7 (22.2) 20.8 (23.7) 23.2 (24.8) 27.8 (29.4) 
SF-36 Mental Health 
Index 
76.9 (14.2) 77.7 (13.7) 78.2 (13.4) 78.5 (13.2) 79.0 (13.1) 
Smoking, %      
     Never 48.6 47.9 46.4 43.9 40.7 
     Past 31.7 36.8 39.5 44.3 50.7 
     Current, 1-14 cig/day 7.0 6.2 6.1 6.0 4.7 
     Current, 15-24 cig/day 8.6 6.6 5.7 4.4 3.1 
     Current, ≥25 cig/day 4.2 2.5 2.3 1.4 0.8 
Alcohol intake, %      
     0 g/d 52.4 41.6 35.4 30.6 24.6 
     1-14 g/d 34.9 48.0 54.8 60.1 67.5 
     ≥15+ g/d 12.7 10.4 9.9 9.3 7.9 
Education, %      
     RN 76.2 72.3 68.8 64.2 59.0 
     Bachelor’s 17.4 19.3 21.3 22.5 24.9 
    Master’s/Doctoral 6.4 8.4 9.9 13.3 16.1 
Hypertension, % 28.5 28.3 28.9 27.8 26.3 
High Cholesterol, % 40.5 42.2 42.8 42.4 42.4 
Myocardial infarction, % 0.7 0.7 0.7 0.8 0.5 
Stroke, % 0.5 0.6 0.6 0.6 0.5 
Type 2 Diabetes, % 3.8 3.7 3.6 3.5 3.2 
Total energy intake, kcal/d 1825 (511) 1770 (515) 1742 (515) 1712 (515) 1699 (511) 
Baseline PFS Score 93.9 (5.3) 94.2 (5.3) 94.5 (5.2) 94.7 (5.1) 95.0 (5.1) 
Values are means(SD) or percentages  
Values of polytomous variables may not sum to 100% due to rounding 
1
Value is not age adjusted 
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AHEI-2010 and Risk of Physical Function Impairment 
In age-adjusted models (Table 1.2), the hazard ratio of incident impairment in physical function 
was 0.71 (95% CI: 0.69, 0.73; P-trend <0.001) comparing women in the highest quintile of 
AHEI-2010 score to the lowest quintile. After controlling for numerous potential confounders, 
this hazard ratio was attenuated, but remained significant (HR=0.87; 95% CI: 0.84, 0.90; P-trend 
<0.001). Results were similar after: excluding participants with a borderline PFS at the start of 
each cycle; imposing a 6 year lag between assessment of diet and of physical function; removing 
vascular factors from multivariable adjusted models; stratifying by hypertension or high 
cholesterol at baseline; modeling physical activity in different ways; and stratifying by age 
(results not shown). In analyses where we examined only baseline/mid-life AHEI-2010 (i.e., we 
did not update diet at each cycle), we found a similar reduced risk of impairment (e.g., for top 
versus bottom quintile of AHEI-2010 in 1990, HR=0.86; 95% CI: 0.83, 0.89). In addition, the 
correlation between diet score at baseline and diet score in 2002 was 0.52, indicating that diet 
patterns remained fairly consistent over time. 
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Table 1.2. Hazards ratios (HR) of incidence physical function impairment (measured by the Physical Function scale of the SF-36), 
according to quintiles of the overall AHEI-2010 score and AHEI-2010 score components 
 
 Quintiles of AHEI Score  
 Q1 Q2 Q3 Q4 Q5 P-trend 
Overall AHEI Score       
Median 39.9 46.8 51.9 57.3 65.2  
Person-years 41,377 45,493 47,158 50,108 53,704  
Age adjusted HR (95% CI) 1.0 (ref) 0.94 (0.91, 0.98) 0.89 (0.86, 0.92) 0.82 (0.79, 0.85) 0.71 (0.69, 0.73) <0.001 
Multivariable adjusted HR 
(95% CI)
1
 
1.0 (ref) 0.96 (0.93, 0.99) 0.93 (0.90, 0.96) 0.90 (0.87, 0.93) 0.87 (0.84, 0.90) <0.001 
 Quintiles of natural categories of AHEI Score Components  
 Q1 Q2 Q3 Q4 Q5 P-trend 
Vegetables       
Median, servings/day 1.63 2.42 3.09 3.90 5.34  
Person-years 42,434 46,635 48,751 49,172 50,848  
Age adjusted HR (95% CI) 1.0 (ref) 0.98 (0.95, 1.02) 0.96 (0.93, 1.00) 0.94 (0.91, 0.97) 0.87 (0.84, 0.90) <0.001 
Multivariable adjusted HR 
(95% CI)
2
 
1.0 (ref) 0.99 (0.96, 1.03) 0.98 (0.95, 1.01) 0.98 (0.95, 1.02) 0.95 (0.91, 0.98) 0.003 
Fruits       
Median, servings/day 0.54 1.01 1.43 1.92 2.81  
Person-years 44,459 47,792 48,913 48,876 47,800  
Age adjusted HR (95% CI) 1.0 (ref) 0.93 (0.90, 0.96) 0.90 (0.87, 0.93) 0.87 (0.84, 0.90) 0.79 (0.77, 0.82) <0.001 
Multivariable adjusted HR 
(95% CI)
2
 
1.0 (ref) 0.95 (0.92, 0.98) 0.96 (0.92, 0.99) 0.95 (0.92, 0.98) 0.94 (0.91, 0.98) 0.02 
Nuts and Legumes       
Median, servings/day 0.07 0.15 0.25 0.38 0.68  
Person-years 43,529 46,267 48,023 49,324 50,697  
Age adjusted HR (95% CI) 1.0 (ref) 1.04 (1.00, 1.07) 1.03 (0.99, 1.06) 1.02 (0.99, 1.05) 0.97 (0.93, 1.00) <0.001 
Multivariable adjusted HR 
(95% CI)
2
 
1.0 (ref) 1.02 (0.98, 1.05) 1.01 (0.97, 1.04) 1.03 (0.99, 1.06) 1.06 (1.02, 1.10) <0.001 
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Table 1.2 (Continued).  
 Quintiles of natural categories of AHEI Score Components   
 Q1 Q2 Q3 Q4 Q5 P-trend 
Red and Processed Meats       
Median, servings/day 0 0.45 0.77 1.10 1.61  
Person-years 46,287 48,844 49,857 48,752 44,100  
Age adjusted HR (95% CI) 1.0 (ref) 0.94 (0.91, 0.97) 1.03 (0.99, 1.06) 1.11 (1.07, 1.14) 1.20 (1.16, 1.24) <0.001 
Multivariable adjusted HR 
(95% CI)
2
 
1.0 (ref) 0.90 (0.87, 0.93) 0.92 (0.89, 0.95) 0.94 (0.91, 0.97) 0.97 (0.94, 1.00) 0.4 
Sugar-Sweetened Beverages       
Median, servings/day 0.18 0.55 0.93 1.29 2.05  
Person-years 47,908 48,423 47,191 48,126 46,192  
Age adjusted HR (95% CI) 1.0 (ref) 1.06 (1.03, 1.10) 1.03 (0.99, 1.06) 1.01 (0.98, 1.04) 1.04 (1.00, 1.07) 0.5 
Multivariable adjusted HR 
(95% CI)
2
 
1.0 (ref) 1.04 (1.00, 1.07) 1.01 (0.98, 1.05) 1.03 (0.99, 1.06) 1.08 (1.04, 1.12) <0.001 
Alcohol       
Median, drinks/day 0 0.4 0.14 0.45 1.27  
Person-years 51,988 31,210 49,156 53,398 52,088  
Age adjusted HR (95% CI) 1.0 (ref) 1.04 (1.00, 1.08) 0.93 (0.90, 0.96) 0.88 (0.85, 0.90) 0.87 (0.84, 0.90) <0.001 
Multivariable adjusted HR 
(95% CI)
2
 
1.0 (ref) 0.94 (0.90, 0.97) 0.91 (0.88, 0.94) 0.90 (0.87, 0.93) 0.92 (0.89, 0.95) 0.02 
Whole Grains       
Median, g/day 5.3 10.9 16.4 23.0 34.9  
Person-years 41,021 47,176 49,132 50,258 50,253  
Age adjusted HR (95% CI) 1.0 (ref) 1.03 (0.99, 1.06) 0.99 (0.96, 1.02) 0.96 (0.92, 0.99) 0.88 (0.85, 0.91) <0.001 
Multivariable adjusted HR 
(95% CI)
2
 
1.0 (ref) 1.00 (0.97, 1.04) 1.00 (0.96, 1.03) 1.01 (0.97, 1.04) 1.03 (1.00, 1.07) 0.04 
Trans Fats       
Median, % of energy 0.009 0.012 0.014 0.017 0.021  
Person-years 52,234 49,654 48,139 43,019 41,794  
Age adjusted HR (95% CI) 1.0 (ref) 1.14 (1.10, 1.17) 1.23 (1.19, 1.27) 1.30 (1.26, 1.34) 1.28 (1.24, 1.32) <0.001 
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Table 1.2 (Continued).  
       
1
 Models adjusted for BMI (continuous), total caloric intake (quintiles), physical activity (<3.0, 3.0-8.9, 9.0-17.9, 18.0-26.9, ≥27 mets/wk), SF-36 
mental health index (continuous), smoking (never, past, current 1-14 cigs/day, current 15-24 cigs/day, ≥25 cigs/day), hypertension (yes, no), high 
cholesterol (yes/no), myocardial infarction (yes/no), stroke (yes/no), type 2 diabetes (yes/no)
 
2 
Models adjusted for BMI (continuous), total caloric intake (quintiles), physical activity (<3.0, 3.0-8.9, 9.0-17.9, 18.0-26.9, ≥27 mets/wk), SF-36 
mental health index (continuous), smoking (never, past, current 1-14 cigs/day, current 15-24 cigs/day, ≥25 cigs/day), hypertension (yes, no), high 
 Quintiles of natural categories of AHEI Score Components   
 Q1 Q2 Q3 Q4 Q5 P-trend 
Trans Fats (cont.)       
Multivariable adjusted HR 
(95% CI)
2
 
1.0 (ref) 0.98 (0.95, 1.01) 1.01 (0.98, 1.04) 1.02 (0.98, 1.05) 1.02 (0.98, 1.06) 0.03 
Omega-3 Fatty Acids       
Median, mg/day 75.5 130 190 270 422.5  
Person-years 44,211 45,915 49,173 49,490 49,051  
Age adjusted HR (95% CI) 1.0 (ref) 1.04 (1.01, 1.07) 101 (0.98, 1.05) 0.98 (0.95, 1.01) 0.95 (0.92, 0.98) <0.001 
Multivariable adjusted HR 
(95% CI)
2
 
1.0 (ref) 1.01 (0.97, 1.04) 0.98 (0.95, 1.01) 0.98 (0.94, 1.01) 0.98 (0.95, 1.02) 0.2 
Polyunsaturated Fatty Acids       
Median, % of energy 4.35 5.14 5.73 6.37 7.41  
Person-years 46,411 48,190 49,007 48,323 45,909  
Age adjusted HR (95% CI) 1.0 (ref) 1.06 (1.02, 1.09) 1.11 (1.08, 1.15) 1.12 (1.08, 1.16) 1.12 (1.08, 1.16) <0.001 
Multivariable adjusted HR 
(95% CI)
2
 
1.0 (ref) 0.97 (0.94, 1.00) 0.99 (0.96, 1.03) 0.98 (0.94, 1.01) 1.01 (0.97, 1.04) 0.6 
Sodium       
Median, mg/day 1357 1772 2102 2479 3113  
Person-years 47,444 49,024 48,730 48,135 44,507  
Age adjusted HR (95% CI) 1.0 (ref) 1.08 (1.04, 1.11) 1.14 (1.10, 1.18) 1.16 (1.12, 1.20) 1.26 (1.21, 1.30) <0.001 
Multivariable adjusted HR 
(95% CI)
2
 
1.0 (ref) 1.04 (1.01, 1.08) 1.09 (1.05, 1.13) 1.10 (1.05, 1.14) 1.15 (1.10, 1.19) <0.001 
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cholesterol (yes/no), myocardial infarction (yes/no), stroke (yes/no), type 2 diabetes (yes/no)
 
andAHEI-2010 score without the component of 
interest.
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AHEI-2010 Score Components, Food Contributors, and Physical Function Impairment 
To ascertain if specific individual components of the AHEI-2010 varied in importance, we 
examined the association between each AHEI-2010 component and risk of incident impairment 
in physical function (Table 1.2). In general, we found modest associations between each 
individual component and physical function, suggesting that overall dietary pattern is more 
important than its components. Only for sodium intake did we find hazard ratios similar in 
magnitude to the overall HR of AHEI-2010 score; comparing extreme quintiles of sodium as 
milligrams per day, the HR was 1.15 (95% CI: 1.10, 1.19; P-trend<0.001) . 
For the five food groups in the AHEI-2010, we also considered the top individual contributors in 
our cohort (by caloric intake) to each food group (Table 1.3). In multivariable-adjusted models, 
similar to findings for AHEI-2010 components, the overall pattern appeared more important than 
individual foods. Among the foods examined, the strongest relations were found for greater 
intake of oranges, orange juice, apples and pears, romaine or leaf lettuce and walnuts; we found a 
HR of 0.91 (95% CI: 0.88, 0.95) for extreme intakes of oranges, a HR of 0.86 (95% CI: 0.81, 
0.92) for extreme intakes of orange juice, a HR of 0.89 (95% CI: 0.82, 0.99) for extreme intakes 
of apples and pears, a HR of 0.88 (95% CI: 0.83, 0.93) for extreme intakes of romaine or leaf 
lettuce, and a HR of 0.93 (95% CI: 0.86, 0.99) comparing those who ate 2 or more servings of 
walnuts per day versus <1 serving per month. 
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Table 1.3. Hazard ratios (HR) of incident physical impairment (measured by the Physical Function scale of the SF-36) by top food 
contributors to AHEI-2010 food components 
 Servings  
 Never or 
<1/month 
1-3/month 1/week ≥2/week P-trend 
Fruits
1
      
Bananas, 1 1.0 (ref) 0.95 (0.90, 1.00) 0.94 (0.89, 0.99) 0.96 (0.91, 1.01) 0.9 
Fresh apples or pears, 1 1.0 (ref) 0.92 (0.85, 1.01) 0.90 (0.82, 0.98) 0.89 (0.82, 0.97) 0.005 
Raisin or grapes, ½ cup 1.0 (ref) 0.95 (0.90, 1.00) 0.98 (0.92, 1.03) 0.97 (0.91, 1.03) 0.2 
Oranges, 1 1.0 (ref) 0.94 (0.90, 0.97) 0.95 (0.91, 0.99) 0.91 (0.88, 0.95) <0.001 
Peaches or plums, 1 fresh or ½ cup canned 1.0 (ref) 0.93 (0.87, 0.99) 0.95 (0.88, 1.00) 0.96 (0.86, 1.02) 0.06 
Vegetables
1
      
Tomatoes, 2 slices 1.0 (ref) 1.04 (0.90, 1.19) 1.08 (0.94, 1.23) 1.05 (0.92, 1.20) 0.4 
Iceberg or head lettuce, 1 cup 1.0 (ref) 0.88 (0.81, 0.97) 0.88 (0.81, 0.97) 0.87 (0.80, 0.95) 0.2 
Onions as a garnish or in salad, 1 slice 1.0 (ref) 0.96 (0.89, 1.05) 0.93 (0.85, 1.01) 0.95 (0.87, 1.02) 0.4 
Romaine or leaf lettuce, 1 cup 1.0 (ref) 0.91 (0.86, 0.97) 0.92 (0.86, 0.98) 0.88 (0.83, 0.93) 0.002 
Raw carrots, ½ a carrot or 2-4 sticks 1.0 (ref) 0.96 (0.92, 1.00) 0.97 (0.93, 1.02) 0.95 (0.91, 0.99) 0.02 
Nuts/Legumes
1,2
      
Peanut butter, 1 Tbs 1.0 (ref) 1.02 (0.98, 1.07) 1.05 (0.99, 1.11) 1.07 (1.02, 1.13) 0.01 
Beans or lentils, ½ cup 1.0 (ref) 0.99 (0.95, 1.03) 0.98 (0.93, 1.03) 1.01 (0.95, 1.07) 0.7 
Peanuts, 1oz. 1.0 (ref) 0.97 (0.93, 1.01) 0.98 (0.92, 1.05) 0.97 (0.90, 1.04) 0.8 
Other nuts, 1oz. 1.0 (ref) 1.05 (1.01, 1.08) 1.06 (0.99, 1.13) 1.05 (0.99, 1.11) 0.2 
Walnuts, 1 oz. 1.0 (ref) 1.00 (0.96, 1.03) 0.93 (0.86, 1.00) 0.93 (0.86, 0.99) 0.02 
Red/Processed Meats
1
      
Beef or lamb as a main dish, 4-6 oz. 1.0 (ref) 1.01 (0.97, 1.06) 1.02 (0.97, 1.07) 1.01 (0.96, 1.07) 0.9 
Beef or lamb as a mixed dish 1.0 (ref) 1.00 (0.96, 1.04) 1.02 (0.97, 1.07) 1.06 (1.01, 1.11) 0.002 
Lean hamburger, 1 patty 1.0 (ref) 0.98 (0.94, 1.03) 1.02 (0.97, 1.07) 1.04 (0.99, 1.10) 0.008 
Pork as a main dish 4-6 oz. 1.0 (ref) 0.89 (0.84, 0.94) 0.88 (0.83, 0.93) 0.89 (0.82, 0.96) 0.1 
Bacon, 2 slices 1.0 (ref) 1.03 (1.01, 1.06) 1.08 (1.05, 1.12) 1.11 (1.06, 1.17) 0.01 
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Table 1.3 (Continued).  
 Servings  
 Never or 
<1/month 
1-3/month 1/week ≥2/week P-trend 
Sugar Sweetened Beverages
1
      
Orange juice, small glass 1.0 (ref) 0.90 (0.84, 0.95) 0.88 (0.82, 0.94) 0.86 (0.81, 0.92) <0.001 
Other fruit juice, small glass 1.0 (ref) 1.05 (1.02, 1.08) 1.08 (1.04, 1.12) 1.11 (1.08, 1.15) <0.001 
Punch, lemonade, sports drinks, or sugared ice tea, 
1 glass, bottle, or can 
1.0 (ref) 0.98 (0.93, 1.03) 0.96 (0.90, 1.02) 1.02 (0.96, 1.08) 0.004 
Carbonated beverage with caffeine and sugar, 1 
glass, bottle, or can 
1.0 (ref) 0.95 (0.93, 0.99) 0.98 (0.93, 1.03) 0.97 (0.93, 1.02) 0.1 
Other carbonated beverages with sugar, 1 glass, 
bottle, or can 
1.0 (ref) 0.90 (0.86, 0.94) 0.94 (0.88, 1.01) 0.99 (0.93, 1.06) 0.007 
 
1
 Models adjusted for BMI (continuous), total caloric intake (quintiles), physical activity (<3.0, 3.0-8.9, 9.0-17.9, 18.0-26.9, ≥27 
mets/wk), SF-36 mental health index (continuous), smoking (never, past, current 1-14 cigs/day, current 15-24 cigs/day, ≥25 cigs/day), 
hypertension (yes, no), high cholesterol (yes/no), myocardial infarction (yes/no), stroke (yes/no), type 2 diabetes (yes/no) and the 
AHEI-2010 score without the component of interest. 
2
 Follow-up started in 2000 
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DISCUSSION 
In this large, prospective study, greater adherence to the AHEI-2010 was associated with a lower 
risk of developing physical impairment over 18 years of follow-up. Overall, the AHEI diet 
pattern appeared more strongly associated with physical function than the individual 
components, or individual foods, although greater intake of vegetables, fruits and moderate 
alcohol, and lower intake of sugar-sweetened beverages, trans fat, and sodium were all 
significantly associated with modestly lower rates of incident physical impairment. Similarly, 
greater intakes of oranges, orange juice, apples and pears, romaine or leaf lettuce, and walnuts 
were associated with reduced risk of physical function impairment.  
 
Our results are consistent with the existing, although limited, literature that supports an 
association between diet quality and physical function. Most prior studies have been cross-
sectional with modest sample sizes. These studies have reported that better diet quality is 
associated with better physical function, as measured by the SF-36 combined with an in-person 
assessment (19), or self-reported disability (20); in two cross-sectional studies which also 
utilized the SF-36 PFS as in our analysis, participants with better diet quality had significantly 
higher mean physical function scores (21, 22). However, in cross-sectional studies, it is plausible 
that better physical function may lead to better diet rather than the reverse. To our knowledge, 
there has been only one prospective study conducted. Among 3,000 participants in a French 
cohort of middle-aged adults, those with best adherence to dietary guidelines had increased 
physical function scores as measured by the SF-36 over the 12 year follow-up period (23), 
consistent with our findings. The epidemiologic research is supported by biologic research 
demonstrating that higher adherence to the AHEI-2010 is associated with a better lipid and 
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inflammatory profile, and decreased risk of clinical vascular disease (6). These factors are all 
strongly related to physical function (7-9) and thus provide a clear biological rationale for the 
findings observed in this analysis.  
 
One somewhat surprising overall finding was that increased intake of nuts and legumes was 
associated with an increased risk of physical impairment. However, after we separated this 
component into the top 5 food contributors, we found the association was driven by increased 
intake of peanut butter, with no increased risk associated with peanuts, or other nuts, and a 
significantly reduced risk of impairment with greater walnut intake. Thus, there is no clear 
explanation for this isolated increase with peanut butter, and it could potentially be a chance 
finding but deserves further investigation. Moreover, recent evidence from the PREDIMED 
randomized trial has demonstrated that a Mediterranean diet (made up of components very 
similar to the AHEI-2010
 
(6)) supplemented with mixed nuts (24), leads to reduced blood 
pressure (25) and LDL cholesterol levels (26) and a reduction in the incidence of type 2 diabetes 
(27) and cardiovascular disease (28) compared to placebo; these are all associated with 
diminished physical function (7-9). 
 
Our study has numerous strengths including the prospective design with 18 years of follow-up, 
multiple measures of diet and physical function, the ability to control for multiple potential 
confounders, and large sample size. Potential limitations also need to be considered. Residual 
confounding cannot be ruled out in an observational study and thus results should be interpreted 
with caution. However, associations between diet quality and physical function remained strong 
and significant after adjustment for a wide array of health and lifestyle factors. Secondly, there is 
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potential for measurement error in both the dietary assessment and the outcome measurement.  
However, both assessment instruments are validated and cumulative averages of diet were used 
to reduce measurement error of the exposure.  Additionally, dietary intake was collected 
prospectively and thus any misreporting of diet is expected to be random and would result in bias 
to the null, suggesting that our results may underestimate true associations.    
 
In summary, we found that better diet quality as measured by the AHEI-2010 was associated 
with a lower risk of incident physical impairment among older women, and that the overall diet 
quality appeared more important than individual components or foods. Given the value of 
physical function to healthy aging and quality of life, this may represent a particularly 
compelling public health rationale for persons to improve their diet.  
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ABSTRACT 
 
Background: Physical function is a key component of healthy aging and is central to quality of 
life in older adults. Numerous studies have consistently demonstrated that women have worse 
physical function with aging compared to men, however, the explanation for this sex difference 
is not fully understood. 
Methods: We utilized data from Nurses’ Health Study and Health Professionals Follow-Up 
Study, two large cohorts of male and female health professionals, with multiple measures of 
physical function, measured by the Medical Outcomes Short Form-36 (SF-36) physical function 
scale (PFS), to examine the role of sex and trajectories of physical function decline.  We used 
multivariable adjusted linear mixed models to estimate the differences in baseline physical 
function and slopes of physical function decline between men and women. We also investigated 
the associations between plasma sex hormone levels, a primary biological factor which could be 
part of the sex difference, and rate of physical function decline in each cohort.  
Results: We found that women have both worse baseline physical function scores at mid-life and 
older ages (age-standardized PFS in men: 86.5 points (95% CI: 86.3, 86.7) vs. PFS in women 
80.4 (95% CI: 80.3, 80.6)), and steeper rates of decline in physical function with aging compared 
to men (age-standardized decline in PFS per year in men: 0.70 points (95% CI: -0.73, -0.68), 
age-standardized decline in PFS per year in women: 1.34 points (95% CI: -1.36, -1.22), (p-value 
for sex-difference <0.001)). In particular, in the youngest age group, those less than 55 years of 
age, risk factor differences – especially body mass index – appeared to account for 
approximately one-quarter of the sex differences in subsequent decline in function. In both 
cohorts, we found no suggestion of a relationship between a variety of plasma hormone levels 
and rate of physical function decline.  
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Conclusions: In this large cohort of middle-aged and older men and women, we found that 
women have consistently worse physical function and steeper rates of decline over time 
compared to men. Given the value of physical function to healthy aging and quality of life, these 
findings suggest a particularly compelling public health rationale for women to improve their 
risk factor profiles to prevent physical function impairments with aging. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
37 
 
INTRODUCTION 
 
Physical function is a key component of healthy aging and is central to quality of life in older 
adults. Prior research has demonstrated that poor physical function is related to hospitalization 
(1), long-term nursing home care (2, 3), and increase mortality (3, 4) among older adults. With 
the proportion of the population 65 years or older expected to increase to nearly 20% by the year 
2030, identifying factors to prevent or delay physical function decline with aging is of great 
importance (5).  
 
Numerous studies have consistently demonstrated that women have worse physical function with 
aging compared to men (6-8). However, the explanation for this sex difference is not fully 
understood. One hypothesis suggests that differences may simply be due to women’s greater 
likelihood to report physical symptoms compared to men (9, 10). However, there is evidence 
from some cross-sectional studies that observed sex differences in physical function may be due 
to risk factor differences, especially varying prevalences of chronic health conditions or lifestyle 
factors (8, 11, 12), yet the cross-sectional studies are somewhat difficult to interpret, since the 
study design does not permit differentiation of cause and effect, and it is possible that health and 
lifestyle may change as a result of physical function rather than explain the onset of impairments 
in function. 
 
To our knowledge, there have been limited prospective studies on the association of sex 
differences in relation to physical function decline. Thus, we utilized data from Nurses’ Health 
Study and Health Professionals Follow-Up Study, two large cohorts of male and female health 
professionals, with multiple measures of physical function to examine this relationship. In 
addition to examining the role of sex and trajectories of physical function decline, we also 
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utilized biological and lifestyle data to address the mechanism underlying this possible sex 
disparity.       
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METHODS 
 
Study Population 
The Nurses’ Health Study (NHS) began in 1976, when 121,700 female registered nurses, aged 
30-55 years, completed a mailed questionnaire on their health and lifestyle. The Health 
Professionals Follow-Up Study (HPFS) is a companion study, which began in 1986 when 51,529 
U.S. male health professionals (dentists, pharmacists, optometrists, osteopath physicians, 
podiatrists, and veterinarians) aged 40-75 years, completed a similar questionnaire. Participants 
have been followed biennially with mailed questionnaires to update information on health and 
lifestyle. The follow-up rate remains approximately >85-90% in both cohorts. The study was 
approved by the Institutional Review Boards of Brigham and Women’s Hospital (Boston, MA) 
and the Harvard School of Public Health (Boston, MA). 
 
Physical Function Assessment 
Information on physical function was collected using the Medical Outcomes Short Form (SF)-36 
questionnaire, a widely used and validated instrument (13). The PFS was administered to 
participants in both cohorts on the mailed questionnaires starting in 1996, and is comprised of 10 
questions regarding physical limitations in performing the following activities: bathing/dressing, 
walking one block, walking several blocks, walking more than one mile, bending/kneeling, 
climbing stairs, lifting groceries, moderate activities, and vigorous activities. Each question has 
the same three possible responses. Each answer of ‘Yes, limited a lot’ is assigned one point, 
‘Yes, limited a little’ is assigned two points, and an answer of ‘No, not limited at all’ is assigned 
three points. A raw score is calculated from the set of 10 questions and ranges from a minimum 
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of 10 points to a maximum of 30 points. The raw score is then transformed to a 100-point scale, 
with a score of 100 considered highest physical function (14). 
 
Measurement of Risk Factors 
Demographic variables included age (continuous in months). Body mass index (BMI, kg/m
2
) 
was calculated from self-reported height and weight. Lifestyle factors included smoking status 
(current, former, never), alcohol consumption (non-drinker, 1-14 g/day, ≥15 g/day), physical 
activity (metabolic equivalent tasks [METs] per week), which was measured using a validated 
physical activity questionnaire, and the Alternative Healthy Eating Index-2010 (AHEI-2010) 
(15), a measure of diet quality. Comorbidities included a history of self-reported type 2 diabetes, 
hypertension, high cholesterol, myocardial infarction, or stroke, which were reported on each 
biennial questionnaire. All these variables were updated at each two-year questionnaire cycle, 
except for AHEI-2010 which was updated every four years. We did not update physical activity 
since levels of physical activity, more so than other variables, may reflect current physical 
function, and thus earlier-life physical activity may be a better marker of confounding than later 
activity. 
 
Biomarker Assessment 
Blood samples were collected from 32,826 women in the NHS from 1989 to 1990 and from 
18,225 men in HPFS from 1993 to 1995. Details on blood draw, transportation, and storage of 
plasma samples have been previous described (16, 17). Briefly, willing participants were sent a 
venipuncture kit, had their blood drawn, and returned the samples to us by overnight mail, on ice. 
Upon receipt by our lab, an average 24 hours after blood draw, samples were processed, 
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aliquotted and stored in liquid nitrogen freezers. In this analysis, measures of sex hormones were 
utilized from previous research in the NHS and HPFS, including nested case-control studies of 
breast cancer, ovarian cancer, colon cancer, prostate cancer, rheumatoid arthritis, inflammatory 
bowel disease, stroke, and myocardial infarction.  
 
Measured sex hormones in NHS included bound levels of plasma estrone, estrone sulfate, 
estradiol, androstenedione, testosterone, dehydroepiandrosterone (DHEA), and 
dehydroepiandrosterone sulfate (DHEA-S). In HPFS, bound levels of plasma estrone, estradiol, 
and testosterone were measured. All hormones except DHEA and DHEA-S were measured by 
radioimmunoassay at the Quest Diagnostics Nichols Institute (San Juan Capistrano, CA) or by 
liquid chromatography-tandem mass spectrometry (ThermoFisher Scientific, Franklin, MA and 
Applied Biosystems-MDS Sciex, Foster City, CA) at the Mayo Medical Laboratories (Rochester, 
MN). DHEA was measured by radioimmunoassay (Diagnostic Systems Laboratories, Webster, 
TX) at Quest Diagnostics or by the quantitative sandwich enzyme immunoassay technique at Dr. 
Nader Rifai’s laboratory at the Department of Laboratory Medicine, Children’s Hospital Boston 
(Boston, MA). DHEA-S was measured by the Immulite 2000 a solid-phase, chemiluminescent 
immunoassay (Siemens Medial Solutions, Los Angeles, CA) at Quest Diagnostics and Mayo 
Medical Laboratories, or by a coated-tube radioimmunoassay at Dr. Rifai’s laboratory. Average 
overall coefficients of variation from the measured batches were within acceptable ranges. We 
adjusted for inter-batch variation using the average-batch calibration method, described by 
Rosner et al (18).  
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Statistical Analysis 
The main analysis of sex differences in physical function included 80,866 women from NHS and 
35,094 men from HPFS. In order to be included in this analysis, participants had to provide 
information on physical function at baseline in 1996. Thus, analyses of baseline physical 
function included all these participants. In analyses of trajectories of function, there were 5,885 
participants in NHS and 3,123 participants in HPFS who were excluded since they did not have 
any measures of physical function after baseline (an additional 13,372 women and 8,263 men 
were excluded after baseline due to death). Women who were lost to follow-up and did not have 
PFS after baseline were highly similar to those who provided data after baseline; for example, 
they were only slightly older (64.2 vs. 62.6 years, respectively), BMI was virtually identical 
(26.2 kg/m
2
 vs. 26.1 kg/m
2
), AHEI-2010 score (53.7 vs. 53.3) was nearly identical, and 
prevalence of former smokers (42.0% vs. 43.6%) was also very similar. Baseline PFS scores in 
women who did not have follow-up measures were less than 5% lower (76.9 vs. 80.3). In men, 
there were also few meaningful differences between those who were lost to follow-up and those 
who contributed to analyses of change in physical function. Thus, we do not expect any 
meaningful bias due to missing physical function data over time.     
 
To calculate age-adjusted baseline physical function and age-adjusted average rate of change in 
physical function per year, we fit linear mixed effect models separately in each cohort; we also 
fit separate models within age strata in each cohort. Models included random varying intercepts 
and slopes to allow for individual physical function trajectories over time. To evaluate the 
association between gender and trajectories of physical function decline, we used multivariable-
adjusted, linear mixed effects models to estimate mean differences in rates of physical function 
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decline over the follow-up period. A series of models were fit, each accounting for additional 
potential risk factor groupings for physical function decline.  
 
Multivariable-adjusted, linear mixed models were also used to test the association between 
plasma hormone levels and trajectories of physical function decline. Tests of trend were 
conducted by modeling the median value of each category of hormone level as a continuous 
variable. All analyses were performed in SAS 9.3 (SAS Institute Inc., Cary, NC).    
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RESULTS 
 
Characteristics of the Study Population 
 
Characteristics of study participants in each cohort at baseline in 1996 are presented in Table 2.1.  
Overall, men and women were similar in mean age, BMI, and AHEI-2010 diet score. Men 
tended to exercise more, smoke cigarettes less, and were more likely to be moderate drinkers 
compared to women. A greater percentage of women had hypertension and high cholesterol 
while a greater percentage of men had a history of myocardial infarction.   
 
Table 2.1. Baseline characteristics of NHS and HPFS participants in 1996 
 
 Women (NHS) 
(n=80,866) 
Men (HPFS) 
(n=32,094) 
Age, yrs 62.6 (7.1) 63.5 (9.3) 
Body mass index, kg/m
2
  26.6 (5.3) 25.9 (3.5) 
Physical activity, MET-hr/week 17.8 (22.0) 29.5 (29.3) 
Smoking, %   
   Never 45.8 43.3 
   Former 43.6 51.2 
   Current 10.6 5.5 
Alcohol intake, %   
   0 g/d 40.1 23.9 
   1-14 g/d 50.9 50.2 
   ≥ 15 g/d 9.0 25.9 
AHEI-2010  53.3 (10.4) 54.3 (11.2) 
Diabetes, % 6.9 6.2 
Hypertension, % 41.1 34.4 
High cholesterol, % 54.6 45.2 
Myocardial infarction, % 1.0 7.9 
Baseline physical function score 80.3 (21.9) 86.7 (19.4) 
Values are means(SD) or percentages  
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Gender Differences in Baseline Physical Function and in Physical Function Decline over 
Time 
 
Overall, after adjusting for age, men had higher physical function scores at baseline compared to 
women (age-standardized PFS score in men: 86.5 points (95% CI: 86.3, 86.7) vs. PFS score in 
women 80.4 (95% CI: 80.3, 80.6)). To examine if these differences may vary by age groups, we 
calculated PFS scores in several age strata. As expected in both men and women, mean PFS 
score decreased with increasing age categories (Table 2.2). However, men consistently had 
higher physical function scores compared to women within each age strata. For example, the 
age-adjusted PFS score in women ≤55 years was 87.2 (95% CI: 86.9, 87.5) and the PFS Score in 
women >65 years was 74.3 (95% CI: 74.0, 74.5); in contrast, the PFS score in men ≤55 years 
was 93.4 (95% CI: 93.1, 93.7, p-value for sex-difference <0.001) and the PFS score in men >65 
year was 79.9 (95% CI: 79.6, 80.3, p-value for sex-difference <0.001). (Table 2.2) 
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Table 2.2. Age-adjusted mixed model results for baseline physical function and average rate of 
change overall, and stratified by age* 
 
 
Women (NHS) Men (HPFS) 
P-value for 
difference 
Overall (n=80,866) (n=35,094)  
Baseline SF-36 Physical Function 
Score 
80.4 (80.3, 80.6) 86.5 (86.3, 86.7) <0.001 
Avg Rate of Change per year -1.34 (-1.36, -1.33) -0.70 (-0.73, -0.68) <0.001 
≤ 55 years of age (n=15,271) (n=8,892)  
Baseline SF-36 Physical Function 
Score 
87.2 (86.9, 87.5) 93.4 (93.1, 93.7) <0.001 
Avg Rate of Change per year -0.66 (-0.69, -0.64) -0.46 (-0.50, -0.43) <0.001 
55-65 years of age (n=33,831) (n=11,040)  
Baseline SF-36 Physical Function 
Score 
83.3 (83.1, 83.5) 90.0 (89.7, 90.3) <0.001 
Avg Rate of Change per year -1.10 (-1.11, -1.08) -0.71 (-0.74, -0.67) <0.001 
> 65 years of age (n=31,764) (n=15,162)  
Baseline SF-36 Physical Function 
Score 
74.3 (74.0, 74.5) 79.9 (79.6, 80.3) <0.001 
Avg Rate of Change per year -1.94 (-1.97, -1.92) -1.38 (-1.42, -1.33) <0.001 
*Physical function determined by score on Medical Outcomes Short Form-36 Physical Function 
Scale, scores can range from 0-100, with higher scores indicating better function. 
 
Similarly, when we examined change in physical function over time, both men and women had 
significant declines in physical function score over time; however, the average rate of decline per 
year was significantly greater in women compared to men. After adjusting for age, we found an 
average decline of 1.34 points (95% CI: -1.36, -1.22) in physical function score per year in 
women, while men on average declined 0.70 points (95% CI: -0.73, -0.68) per year (p-value for 
sex-difference <0.001). When we stratified by age, in both men and women, the average rate of 
decline increased with increasing age category (Table 2.2), however, within each age category, 
women still declined at a significantly faster rate compared to men (all p-values<0.001). (Table 
2.2) 
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Physical Function Risk Factors Differences in Men and Women 
To evaluate to what extent the observed sex differences in physical function and rate of decline 
could be explained by differences in risk factors in men and women, we created a series of 
models, including various groups of physical function risk factors. In the first model, including 
only age as a covariate, the mean difference in baseline physical function for women versus men 
was -5.16 points (95% CI: -5.42, -4.90) and the mean difference in the rate of decline in physical 
function score per year was -0.43 points (95% CI: -0.46, -0.41). When we added BMI to the 
model, the mean baseline difference was attenuated by 13%, indicating differences in BMI 
between the sexes partially explained the observed differences in physical function (mean 
baseline difference in women vs. men: -4.51 (95% CI: -4.77, -4.26)). In subsequent models 
adding health behaviors (smoking status, alcohol consumption, AHEI-2010 score) and 
comorbidities (hypertension, high cholesterol, myocardial infarction, type II diabetes), both 
estimates were further attenuated, although to a lesser extent. In a model including all these risk 
factors for physical function decline and baseline physical activity, we found that these risk 
factors taken together explained over 45% of the observed sex difference in baseline physical 
function score and 12% of the observed difference in mean rate of decline (mean baseline 
difference in women vs men: -2.74 (95% CI: -3.00,-2.47), mean difference in annual rate of 
change for women vs. men: -0.38 (95% CI: -0.41, -0.36)). We also looked at a model with all 
risk factors except for physical activity since we were concerned about the interpretation of 
physical activity in models for physical function and the possibility of reverse causation. In this 
model, the baseline difference comparing women vs. men was -4.10 (95% CI: -4.36, -3.83) and 
the mean difference in annual rate of change was nearly identical to the estimate from the model 
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including physical activity (mean difference for women vs. men: -0.38 (95% CI: -0.41, -0.36)). 
(Table 2.3)     
Table 2.3. Mean difference baseline physical function difference and annual rate of change in 
physical function, in women versus men*  
 Mean baseline difference for 
women vs. men 
Mean difference in annual rate of 
change for women vs. men 
Overall   
Model 1 -5.16 (-5.42, -4.90) -0.43 (-0.46, -0.41) 
Model 2 -4.51 (-4.77, -4.26) -0.45 (-0.48, -0.43) 
Model 3 -3.96 (-4.21, -3.70) -0.40 (-0.43, -0.38) 
Model 4 -4.10 (-4.36, -3.83) -0.39 (-0.42, -0.37) 
Model 5 -2.74 (-3.00, -2.47) -0.38 (-0.41, -0.36) 
≤ 55 years of age at baseline 
Model 1 -5.02 (-5.58, -4.45) -0.29 (-0.34, -0.24) 
Model 2 -4.64 (-5.19, -4.08) -0.24 (-0.29, -0.19) 
Model 3 -4.33 (-4.89, -3.77) -0.22 (-0.27, -0.17) 
Model 4 -4.26 (-4.82, -3.70) -0.22 (-0.27, -0.17) 
Model 5 -3.66 (-4.23, -3.09) -0.22 (-0.27, -0.17) 
55-65 years of age at baseline 
Model 1 -5.48 (-5.92, -5.04) -0.44 (-0.48, -0.40) 
Model 2 -4.95 (-5.39, -4.52) -0.45 (-0.50, -0.41) 
Model 3 -4.34 (-4.78, -3.90) -0.41 (-0.45, -0.37) 
Model 4 -4.37 (-4.81, -3.93) -0.40 (-0.44, -0.36) 
Model 5 -3.27 (-3.71, -2.82) -0.39 (-0.43, -0.35)  
> 65 years of age at baseline 
Model 1 -6.40 (-6.84, -5.95) -0.61 (-0.66, -0.56) 
Model 2 -5.78 (-6.23, -5.34) -0.68 (-0.73, -0.62) 
Model 3 -5.69 (-6.13, -5.25) -0.65 (-0.70, -0.60) 
Model 4 -5.49 (-5.95, -5.03) -0.58 (-0.63, -0.52) 
Model 5 -3.37 (-3.83, -2.91) -0.55 (-0.61, -0.50) 
*Physical function determined by score on Medical Outcomes Short Form-36 Physical Function 
Scale, scores can range from 0-100, with higher scores indicating better function. 
Model 1 adjusts for age (continuous).  
Model 2 adjusts for age (continuous), BMI (continuous). 
Model 3 adjusts for age (continuous), BMI (continuous), smoking status (never, past, current), 
alcohol consumption (0 g/d, 1-14g/d, 15+ g/d), AHEI-2010 (continuous) 
Model 4 adjusts for age (continuous), BMI (continuous), smoking status (never, past, current), 
alcohol consumption (0 g/d, 1-14g/d, 15+ g/d), AHEI-2010 (continuous) hypertension (yes/no), 
high cholesterol (yes/no), myocardial infarction (yes/no), type 2 diabetes (yes/no). 
Model 5 adjusts for age (continuous), BMI (continuous), smoking status (never, past, current), 
alcohol consumption (0 g/d, 1-14g/d, 15+ g/d), AHEI-2010 (continuous) hypertension (yes/no), 
high cholesterol (yes/no), myocardial infarction (yes/no), type 2 diabetes (yes/no), physical 
activity (continuous) 
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We also examined these models after stratifying by age. Overall, we found that risk factors 
explained more of the observed sex differences for physical function decline among younger 
participants compared to older participants. (Table 2.3) Among those 55 years of age or less at 
baseline, risk factors explained 24% of the observed difference in mean rate of decline (mean 
difference in annual rate of change for women vs. men: -0.22 (95% CI: -0.27, -0.17)). While 
among those over 65 years of age at baseline, risk factors explained 5% of the observed 
difference in mean rate of decline (mean difference in annual rate of change for women vs. men: 
-0.58 (95% CI: -0.63, -0.52)). 
 
Sex Hormones and Physical Function 
We also examined sex hormones as primary biological factors which could be part of sex 
differences in physical function. We investigated the associations between plasma sex hormone 
levels and rate of physical function decline in each cohort. In both cohorts, we found no 
suggestion of a relationship between a variety of plasma hormone levels and rate of physical 
function decline. For example, among women, comparing those in the highest to lowest quartile 
of plasma estradiol, we found no difference in mean rate of physical function decline, after 
multivariable adjustment (mean difference -0.01 (95% CI: -0.19, 0.16, p-trend=0.8). Results 
were similar for estrone and also for testosterone levels in women (Q4 vs Q1: estrone: -0.01, 
95% CI: -0.18, 0.16, p-trend=0.9, testosterone: -0.08, 95% CI: -0.19, 0.03, p-trend=0.1) (Table 
2.4). Similarly, among men, comparing those in highest to lowest tertile of plasma hormone 
levels (due to the smaller sample of men with relevant data, we created tertiles rather quartiles), 
we found null results for mean differences in rates of physical function decline (T3 vs T1: 
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estradiol: -0.11, 95% CI: -0.49, 0.29, p-trend=0.6, estrone: -0.26, 95% CI: -0.78, 0.29, p-
trend=0.4, testosterone: -0.08, 95% CI: -0.44, 0.26, p-trend=0.7) (Table 2.5).  
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Table 2.4. Mean differences in slopes of physical function decline in the Nurses’ Health Study by quartiles of plasma hormone levels 
 
 
Q1 
(reference) 
Q2 Q3 Q4 p-trend 
Estradiol (n=2,682)      
Median 3.52 pg/mL 5.10 pg/mL 7.37 pg/mL 12.51 pg/mL  
Model 1 0.00 -0.15 (-0.30, 0.01) -0.13 (-0.29, 0.02) -0.25 (-0.41, -0.10) 0.004 
Model 2 0.00 -0.10 (-0.25, 0.06) -0.03 (-0.18, 0.13) -0.01 (-0.19, 0.16) 0.8 
Estrone (n=2,559)      
Median 15.34 pg/mL 22.40 pg/mL 30.05 pg/mL 44.73 pg/mL  
Model 1 0.00 -0.03 (-0.19, 0.13) -0.09 (-0.25, 0.07) -0.18 (-0.34, -0.02) 0.02 
Model 2 0.00 -0.03 (-0.19, 0.13) -0.03 (-0.20, 0.13) -0.01 (-0.18, 0.16) 0.9 
Testosterone (n=5,326)      
Median 10.87 ng/dL 16.85 ng/dL 23.27 ng/dL 34.90 ng/dL  
Model 1 0.00 -0.02 (-0.13, 0.09) -0.07 (-0.18, 0.04) -0.10 (-0.21, 0.01) 0.06 
Model 2 0.00 -0.03 (-0.14, 0.08) -0.06 (-0.17, 0.05) -0.08 (-0.19, 0.03) 0.1 
Model 1 adjusts for age (continuous) 
Model 2 adjusts for age (continuous), BMI (continuous), smoking status (never, past, current), alcohol consumption (0 g/d, 1-14g/d, 
15+ g/d), AHEI-2010 (continuous) hypertension (yes/no), high cholesterol (yes/no), myocardial infarction (yes/no), type 2 diabetes 
(yes/no), physical activity (continuous) 
 
 
 
 
 
 
52 
 
 
 
 
Table 2.5. Mean differences in slopes of physical function decline in the Health Professionals Follow-Up Study by tertiles of plasma 
hormone levels 
 
 
T1 
(reference) 
T2 T3 p-trend 
Estradiol (n=1,165)     
Median 18.83 pg/mL 25.11 pg/mL 32.11 pg/mL  
Model 1 0.00 0.11 (-0.15, 0.37) -0.03 (-0.29, 0.24) 0.8 
Model 2 0.00 0.14 (-0.23, 0.51) -0.11 (-0.49, 0.28) 0.6 
Estrone (n=611)     
Median 20.75 pg/mL 29.16 pg/mL 39.96 pg/mL  
Model 1 0.00 -0.02 (-0.39, 0.34) -0.21 (-0.58, 0.17) 0.3 
Model 2 0.00 0.03 (-0.47, 0.54) -0.25 (-0.78, 0.29) 0.4 
Testosterone (n=1,387)     
Median 10.87 ng/mL 16.85 ng/mL 23.27 ng/mL  
Model 1 0.00 -0.08 (-0.32, 0.16) 0.01 (-0.24, 0.25) 0.9 
Model 2 0.00 -0.13 (-0.49, 0.22) -0.09 (-0.44, 0.26) 0.7 
Model 1 adjusts for age (continuous) 
Model 2 adjusts for age (continuous), BMI (continuous), smoking status (never, past, current), alcohol consumption (0 g/d, 1-14g/d, 
15+ g/d), AHEI-2010 (continuous) hypertension (yes/no), high cholesterol (yes/no), myocardial infarction (yes/no), type 2 diabetes 
(yes/no), physical activity (continuous) 
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DISCUSSION 
In this large, prospective study of women and men, we found gender differences in physical 
function at baseline and in trajectories of physical function decline over time. Even across age 
strata, women had consistently worse baseline physical function and steeper rates of decline 
compared to men. In particular, we found that risk factors appeared to explain 24% of the 
differences in physical function decline in the youngest age group (≤55 years), indicating that it 
could be of particular importance to intervene on risk factors in women to prevent further 
physical function impairments with aging. 
 
These findings are consistent with prior literature regarding gender differences and physical 
function (6-8, 10, 19, 20). For example, among a cohort of 10,263 U.S community dwelling 
adults followed for up to 7 years, women were more likely to report impairments in mobility 
(inability to climb stairs or inability to walk half a mile without assistance) and were more likely 
to continue to report impairments in mobility over the follow-up period compared to men 
(relative risk comparing men vs. women for recovering from an impairment: 0.72 (95% CI: 0.53, 
0.98)) (7). Other studies have also reported similar findings; however, most have been cross-
sectional and could not evaluate whether differences were only at a single time point or persisted 
over time (6, 10). 
 
 
Overall, we found that differences in the risk factor profiles of women and men explained 20% 
of the sex differences in baseline physical function and 9% of the sex differences in annual rate 
of change. Most importantly however, among the youngest age group (≤55 years of age at 
baseline), risk factors differences explained 24% of the difference in annual rate of change for 
women compared to men, suggesting that risk factor modification could be especially beneficial 
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in younger women to prevent further losses in physical function with aging. Moreover, we 
observed that BMI accounted for the greatest attenuation in the mean difference in change for 
women vs. men compared with the other risk factors in the ≤55 age group. These findings are 
consistent with prior studies that have investigated differences in body composition and BMI as 
possible explanations for sex differences in physical function. In the Health, Aging and Body 
Composition study, higher fat mass explained 35% of the poorer physical function observed 
among women compared to men (21). Taken together with the findings in this analysis, research 
suggests that women should be particularly encouraged to achieve and maintain a healthy weight 
at middle age to prevent impairments in physical function and physical function decline. 
 
 
A strength of this analysis was our ability to investigate numerous potential risk factors and 
evaluate their impact in explaining sex differences in physical function and physical function 
decline. However, there could be other potential, unknown risk factors that could be important in 
explaining the observed sex differences.  One hypothesis that has been put forth for these gender 
differences is that women are more likely to report symptoms of physical impairment compared 
to men (8, 9). It is possible that our participants, as health professionals, are more accurate at 
reporting health symptoms such as physical function, although we have no means of assessing 
their tendency to report such symptoms here.  
 
Sex differences in physical function could also be due to biological differences between men and 
women. In this analysis, we also explored how plasma sex hormones were related to physical 
function decline in women and men, as a way to examine a primary biological difference 
between the sexes. However, we found no evidence of a relationship between plasma estrogens 
or testosterone levels and subsequent trajectories of physical function decline in men or women. 
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To our knowledge, there has been one other study that has studied this relationship. In a cross-
sectional analysis of 1,200 older adults, there were no associations in men or women found 
between total estradiol levels or total testosterone levels with physical performance or physical 
limitations. However, it was found that men in the highest quartile of estradiol/SHBG ratio had 
significantly greater physical performance compared to men in the lowest quartile and 
bioavailable testosterone was positively associated with physical performance in men (22). 
Nonetheless, there certainly is not convincing evidence that sex hormones may play a role in 
physical function, and it remains unclear whether biologic differences between women and men 
may help to explain observed sex differences in physical function.      
 
Our study has numerous strengths including the prospective design with over 10 years of follow-
up, multiple measures of physical function over time, the ability to investigate multiple potential 
risk factors and biological data, and a large sample size. Potential limitations also need to be 
considered. There is potential for measurement error in both the assessment of risk factors and 
the outcome measurement. We would expect any misreporting of risk factors to be random and 
thus results would be biased toward the null, suggesting there could be further attenuation of the 
estimates for gender differences in relation to physical function decline with more accurate 
measurements of risk factors; thus, we could be somewhat underestimating the extent to which 
risk factor differences explain sex differences. Finally, our study population was homogenous, 
comprised of predominately white health professionals, thus it is possible our findings may not 
be generalizable to other racial or ethnic groups. However, the homogeneity and the uniform 
health education of this population should provide strong internal validity of our findings. 
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In summary, we found that women have both worse baseline physical function scores at mid-life 
and older ages, and steeper rates of decline in physical function with aging, compared to men.  In 
particular, in the youngest age group we examined, those less than 55 years of age, risk factor 
differences – especially body mass index – appeared to account for approximately one-quarter of 
the sex differences in subsequent decline in function. Our findings suggest that middle-aged 
women may be targeted for risk factors modification, including weight counseling. Given the 
value of physical function to healthy aging and quality of life for most people, this may represent 
a particularly compelling public health rationale for women to improve their risk factor profiles 
to prevent physical function impairments with aging. 
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